医学
肾脏疾病
肾病科
精密医学
背景(考古学)
急性肾损伤
内科学
肾功能
肾
疾病
内型
生物信息学
重症监护医学
病理
生物
古生物学
作者
Tarek M. El‐Achkar,Michael T. Eadon,Matthias Kretzler,Jonathan Himmelfarb,Blue B. Lake,Kun Zhang,Stewart H. Lecker,Alexander Morales,Steve Bogen,Afolarin Amodu,Laurence H. Beck,Joel Henderson,Titlayo Ilori,Shana Maikhor,Ingrid Onul,Insa M. Schmidt,Ashish Verma,Sushrut S. Waikar,Pranav Yadati,Guanghao Yu
标识
DOI:10.1053/j.ajkd.2023.08.015
摘要
Chronic kidney disease (CKD) and acute kidney injury (AKI) are heterogeneous syndromes defined clinically by serial measures of kidney function. Each condition possesses strong histopathologic associations, including glomerular obsolescence or acute tubular necrosis, respectively. Despite such characterization, there remains wide variation in patient outcomes and treatment responses. Precision medicine efforts, as exemplified by the Kidney Precision Medicine Project (KPMP), have begun to establish evolving, spatially anchored, cellular and molecular atlases of the cell types, states, and niches of the kidney in health and disease. The KPMP atlas provides molecular context for CKD and AKI disease drivers and will help define subtypes of disease that are not readily apparent from canonical functional or histopathologic characterization but instead are appreciable through advanced clinical phenotyping, pathomic, transcriptomic, proteomic, epigenomic, and metabolomic interrogation of kidney biopsy samples. This perspective outlines the structure of the KPMP, its approach to the integration of these diverse datasets, and its major outputs relevant to future patient care.
科研通智能强力驱动
Strongly Powered by AbleSci AI